Risk Factors in Patients with Pathological Stage I Non-Small Cell Lung Cancer

被引:0
|
作者
Tokunaga, Yoshimasa [1 ]
Okamoto, Taku [1 ]
Chang, Sung Soo [1 ]
机构
[1] Kochi Hlth Sci Ctr, Dept Gen Thorac Surg, Kochi, Japan
关键词
pathological stage I; non-small cell lung cancer; risk factor;
D O I
10.1016/j.jtho.2016.11.861
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.05-076
引用
收藏
页码:S662 / S662
页数:1
相关论文
共 50 条
  • [41] Determination of prognostic factors of surgically treated pathological Stage IIIA non-small cell lung cancer
    Sayan, Muhammet
    Valiyev, Elgun
    Turk, Merve Satir
    Bas, Aynur
    Celik, Ali
    Kurul, Ismail Cuneyt
    Aribas, Olgun Kadir
    Tastepe, Abdullah Irfan
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2020, 28 (03): : 496 - 504
  • [42] Clinical staging underestimates pathological stage in non-small cell lung cancer
    Camporota, L
    THORAX, 2005, 60 (07) : 581 - 581
  • [43] Therapy for stage I and stage II non-small cell lung cancer
    Tanoue, LT
    Ponn, RB
    CLINICS IN CHEST MEDICINE, 2002, 23 (01) : 173 - +
  • [44] Proton beam therapy for patients with stage I non-small cell lung cancer
    Nakayama, H.
    Tokuuye, K.
    Sugahara, S.
    Kurishima, K.
    Fukumitsu, N.
    Satoh, H.
    Hizawa, N.
    Tsuboi, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S435 - S435
  • [45] Serum lipidome screening in patients with stage I non-small cell lung cancer
    Klupczynska, Agnieszka
    Plewa, Szymon
    Kasprzyk, Mariusz
    Dyszkiewicz, Wojciech
    Kokot, Zenon J.
    Matysiak, Jan
    CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 19 (04) : 505 - 513
  • [46] Survival of Patients With True Pathologic Stage I Non-Small Cell Lung Cancer
    Cerfolio, Robert J.
    Bryant, Ayesha S.
    ANNALS OF THORACIC SURGERY, 2009, 88 (03): : 917 - 923
  • [47] Serum lipidome screening in patients with stage I non-small cell lung cancer
    Agnieszka Klupczynska
    Szymon Plewa
    Mariusz Kasprzyk
    Wojciech Dyszkiewicz
    Zenon J. Kokot
    Jan Matysiak
    Clinical and Experimental Medicine, 2019, 19 : 505 - 513
  • [48] WEDGE RESECTION AND SEGMENTECTOMY IN PATIENTS WITH STAGE I NON-SMALL CELL LUNG CANCER
    Syrigos, Konstantinos N.
    Boura, Paraskevi
    Tsapas, Charris
    Nikolaou, Aristidis
    Kalavrouziotis, Georgios
    Reveliotis, Konstantinos
    Charpidou, Andriani
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S809 - S809
  • [49] PULMONARY RESECTION FOR STAGE I NON-SMALL CELL LUNG CANCER IN ELDERLY PATIENTS
    Park, Byungjoon
    Kim, Jhingook
    Shim, Young Mog
    Zo, Jae Il
    Choi, Yong Soo
    Lee, Genehee
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1106 - S1106
  • [50] Risk factors for recurrence after complete resection of pathological stage N2 non-small cell lung cancer
    Qiang, Guangliang
    Liang, Chaoyang
    Yu, Qiduo
    Xiao, Fei
    Song, Zhiyi
    Tian, Yanchu
    Shi, Bin
    Liu, Deruo
    Guo, Yongqing
    THORACIC CANCER, 2015, 6 (02) : 166 - 171